Hakim Nasrat A

CEO, President, Director, 10% Owner

Avg. Two Year Performance

(45%) Avg. Purchase Return    (20%) Compound
No Sale Track Record

Holdings: 221.57M shares

Last Three Months: 19-Feb-24 -- 18-May-24

0 Net Amount
Buy:0--
Sell:0--

Sentiment

Insider Trading Sentiment: Accumulate

Company Sentiment

Drug Manufacturers - Other

Drugs

Insider Trading Sentiment:
Insider Trading Sentiment:
Insider Trading Sentiment:

Two Year Chart

19-May-22 -- 18-May-24

Price ($)

Sentiment

Company Sentiment

Most Recent Insider Transactions